Advancing hypoparathyroidism treatment: FDA approval of Palopegteriparatide as a promising orphan drug
推进甲状旁腺功能减退症的治疗:FDA批准帕洛佩格特里帕肽作为一种有前景的孤儿药
期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000004734
Shahid, Syeda Rabiah; Shahid, Kamran; Ehsan, Sikandar; Khalid, Maliha; Waafira, Aminath